Targeted Delivery and Prodrug Designs for Platinum-Acridine Anti-Cancer Compounds and Methods Thereof
    1.
    发明申请
    Targeted Delivery and Prodrug Designs for Platinum-Acridine Anti-Cancer Compounds and Methods Thereof 有权
    用于铂 - 吖啶类抗癌化合物的靶向递送和前药设计及其方法

    公开(公告)号:US20140193334A1

    公开(公告)日:2014-07-10

    申请号:US14241900

    申请日:2012-08-30

    摘要: Acridine containing cisplatin compounds have been disclosed that show greater efficacy against cancer than other cisplatin compounds. Methods of delivery of those more effective cisplatin compounds to the nucleus in cancer cells is disclosed using one or more amino acids, one or more sugars, one or more polymeric ethers, C1-6alkylene-phenyl-NH—C(O)—R15, folic acid, αvβ3 integrin RGD binding peptide, tamoxifen, endoxifen, epidermal growth factor receptor, antibody conjugates, kinase inhibitors, diazoles, triazoles, oxazoles, erlotinib, and/or mixtures thereof; wherein R15 is a peptide.

    摘要翻译: 已经公开了含有吖啶的顺铂化合物,其显示出比其他顺铂化合物更有效的抗癌作用。 公开了使用一种或多种氨基酸,一种或多种糖,一种或多种聚合醚,C 1-6亚烷基 - 苯基-NH-C(O)-R 15,C 1-6亚烷基 - 苯基-NH- 叶酸,αv&bgr; 3整合素RGD结合肽,他莫昔芬,内皮素,表皮生长因子受体,抗体缀合物,激酶抑制剂,二唑,三唑,恶唑,厄洛替尼和/或其混合物; 其中R15是肽。

    Targeted delivery and prodrug designs for platinum-acridine anti-cancer compounds and methods thereof
    2.
    发明授权
    Targeted delivery and prodrug designs for platinum-acridine anti-cancer compounds and methods thereof 有权
    铂 - 吖啶类抗癌化合物的靶向递送和前药设计及其方法

    公开(公告)号:US09090640B2

    公开(公告)日:2015-07-28

    申请号:US14241900

    申请日:2012-08-30

    摘要: Acridine containing cisplatin compounds have been disclosed that show greater efficacy against cancer than other cisplatin compounds. Methods of delivery of those more effective cisplatin compounds to the nucleus in cancer cells is disclosed using one or more amino acids, one or more sugars, one or more polymeric ethers, C1-6alkylene-phenyl-NH—C(O)—R15, folic acid, αvβ3 integrin RGD binding peptide, tamoxifen, endoxifen, epidermal growth factor receptor, antibody conjugates, kinase inhibitors, diazoles, triazoles, oxazoles, erlotinib, and/or mixtures thereof; wherein R15 is a peptide.

    摘要翻译: 已经公开了含有吖啶的顺铂化合物,其显示出比其他顺铂化合物更有效的抗癌作用。 公开了使用一种或多种氨基酸,一种或多种糖,一种或多种聚合醚,C 1-6亚烷基 - 苯基-NH-C(O)-R 15,C 1-6亚烷基 - 苯基-NH- 叶酸,αv&bgr; 3整合素RGD结合肽,他莫昔芬,内皮素,表皮生长因子受体,抗体缀合物,激酶抑制剂,二唑,三唑,恶唑,厄洛替尼和/或其混合物; 其中R15是肽。

    Water soluble transplatinum complexes with anti-cancer activity and
method of using same
    4.
    发明授权
    Water soluble transplatinum complexes with anti-cancer activity and method of using same 失效
    具有抗癌活性的水溶性复合物及其使用方法

    公开(公告)号:US6001872A

    公开(公告)日:1999-12-14

    申请号:US263222

    申请日:1999-03-05

    IPC分类号: C07F15/00 A61K31/28

    CPC分类号: C07F15/0093

    摘要: The present invention relates to the treatment of tumors with a novel water soluble trans-platinum coordination compound having the general structural formula [PtBX.sub.m (NR*.sub.3)] where B is a planar, heterocyclic ring containing at least one nitrogen atom, and a pendant chelating group; and X is an anionic ligand; and R* is hydrogen or a lower alkyl.

    摘要翻译: 本发明涉及用具有通式[PtBXm(NR * 3)]的新型水溶性反式铂配位化合物治疗肿瘤,其中B是含有至少一个氮原子的平面杂环,和一个侧基 螯合基团 X为阴离子配体; 和R *是氢或低级烷基。

    Platinum complexes with anti-viral activity and method of using same
    5.
    发明授权
    Platinum complexes with anti-viral activity and method of using same 失效
    具有抗病毒活性的铂复合物及其使用方法

    公开(公告)号:US6113934A

    公开(公告)日:2000-09-05

    申请号:US95565

    申请日:1998-06-11

    CPC分类号: A61K31/522 A61K31/282

    摘要: The present invention relates to treatment of viral infections, such as HIV, with a new class of anti-viral platinum coordination compounds having the general structural formula [PtXA.sub.m B.sub.3-m ] where X is an anionic ligand, A is an acyclic, nitrogen containing monodentate ligand such as amines, ammines, and quinolines, and B is nucleobase.

    摘要翻译: 本发明涉及通过具有一般结构式[PtXAmB3-m]的新类型的抗病毒铂配位化合物治疗病毒感染如HIV,其中X是阴离子配体,A是无环的含氮单齿 配体如胺,氨和喹啉,B是核碱基。